GlassScriptPhysician profile
Lawrence P Clinton
NPI 1316003734
$2,636.28
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $692 · 2021: $554 · 2022: $266.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $529.72 | 2019-2020 | |
| Abbvie INC. | $445.99 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $326.34 | 2019-2021 | |
| Lundbeck LLC | $256.61 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $218.49 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $188.43 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $126.97 | 2020 | |
| Avanir Pharmaceuticals, INC. | $108.15 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $105.34 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.15 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $52.28 | 2019-2022 | |
| Adlon Therapeutics L.P. | $41.23 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $40.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.01 | 2019 | |
| Shire North American Group INC | $39.08 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $13.80 | 2021 | |
| Alkermes, INC. | $13.60 | 2019 | |
| Neos Therapeutics, LP | $13.18 | 2020 | |
| Bausch Health US, LLC | $12.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Clinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.